abstract |
Monoclonal antibodies, altered antibodies, humanized antibodies, chimeric antibodies, and a pharmaceutical composition containing the altered antibody are disclosed. These monoclonal antibodies are effective against coagulation factor and find use for inhibiting thrombosis. |